Oncology Product Line

ChemWerth’s goal is to develop an FDA approved source for every injectable oncology product that comes off patent. To date, our 28 years of technical expertise has supported numerous manufacturers of oncology Active Pharmaceutical Ingredients gain FDA approval. Products offered by ChemWerth as injectable-grade are produced in modern cGMP-compliant clean rooms and are strictly controlled for endotoxins and bioburden.

Amifostine 3H2O USP**
Aprepitant
Arsenic Trioxide
Azacitidine
Busulfan
Carboplatin USP
Cisplatin USP
Docetaxel
Etoposide USP
Exemestane
Fosaprepitant Dimeglumine

Fulvestrant
Gemcitabine HCl USP
Ifosfamide USP
Irinotecan HCl 3H2O
Mitoxantrone HCl USP/PhEur
Oxaliplatin
Pemetrexed Disodium
Temozolomide
Topotecan HCl
Vinorelbine Tartrate USP
Zoledronic Acid

** Pending Approval
Items denoted by blue text have been approved in the USA/EP